Cachet Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002462.SZ

Cachet Pharmaceutical Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 0.12

Cachet Pharmaceutical Co., Ltd. Price to Sales Ratio (P/S) is 0.12 on January 14, 2025, a -16.41% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Cachet Pharmaceutical Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 0.14 on January 15, 2024, which is 19.63% above the current Price to Sales Ratio (P/S).
Cachet Pharmaceutical Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 0.10 on February 05, 2024, which is -14.95% below the current Price to Sales Ratio (P/S).
Cachet Pharmaceutical Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.12.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shenzhen Stock Exchange: 002462.SZ

Cachet Pharmaceutical Co., Ltd.

CEO	Mr. Yibin Huang
IPO Date	Aug. 18, 2010
Location	China
Headquarters	Building 1
Employees	2,357
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale

Description

Cachet Pharmaceutical Co., Ltd. engages in the wholesale and retail sale of pharmaceutical products in China. It is involved in the supply of medicines to hospitals; wholesale of biological products, medical instruments, and traditional Chinese medicines; pharmaceutical logistic operations; and manufacture of medicines. The company owns 150 chain stores in Beijing that sell medicines, health care foods, medical instruments, cosmetics, daily necessities, and traditional Chinese medicines. Cachet Pharmaceutical Co., Ltd. was founded in 1998 and is based in Beijing, China.

Key trends

Past 5 years